Resource Logo
NLM AIDSLINE

Prevention of Th2-like cell responses by coadministration of IL-12 and IL-18 is associated with inhibition of antigen-induced airway hyperresponsiveness, eosinophilia, and serum IgE levels.




 

J Immunol. 1998 Nov 1;161(9):5054-60. Unique Identifier : AIDSLINE

Allergic asthma is thought to be regulated by Th2 cells, and inhibiting this response is a promising mode of intervention. Many studies have focused on differentiation of Th cells to the Th1 or Th2 subset in vitro. IL-4 is essential for Th2 development, while IL-12 induces Th1 development, which can be enhanced by IL-18. In the present study, we investigated whether IL-12 and IL-18 were able to interfere in Th2 development and the associated airway symptoms in a mouse model of allergic asthma. Mice were sensitized with OVA using a protocol that induces IgE production. Repeated challenges by OVA inhalation induced elevated serum levels of IgE, airway hyperresponsiveness, and a predominantly eosinophilic infiltrate in the bronchoalveolar lavage concomitant with the appearance of Ag-specific Th2-like cells in lung tissue and lung-draining lymph nodes. Whereas treatments with neither IL-12 nor IL-18 during the challenge period were effective, combined treatment of IL-12 and IL-18 inhibited Ag-specific Th2-like cell development. This inhibition was associated with an absence of IgE up-regulation, airway hyperresponsiveness, and cellular infiltration in the lavage. These data show that, in vivo, the synergistic action of IL-12 and IL-18 is necessary to prevent Th2-like cell differentiation, and consequently inhibits the development of airway symptoms in a mouse model of allergic asthma.

JOURNAL ARTICLE Animal Asthma/IMMUNOLOGY/*THERAPY Biological Response Modifiers/PHARMACOLOGY/*THERAPEUTIC USE Bronchial Hyperreactivity/CHEMICALLY INDUCED/IMMUNOLOGY/PATHOLOGY/ *PREVENTION & CONTROL Bronchoalveolar Lavage Fluid/CYTOLOGY Cell Differentiation/DRUG EFFECTS Cells, Cultured Cytokines/SECRETION Drug Synergism Eosinophilia/CHEMICALLY INDUCED/IMMUNOLOGY/*PREVENTION & CONTROL IgE/*BLOOD Interleukin-12/PHARMACOLOGY/*THERAPEUTIC USE Interleukin-18/PHARMACOLOGY/*THERAPEUTIC USE Lung/PATHOLOGY/SECRETION Lymph Nodes/PATHOLOGY/SECRETION Male Mice Mice, Inbred BALB C Ovalbumin/IMMUNOLOGY/TOXICITY Recombinant Proteins/PHARMACOLOGY/THERAPEUTIC USE Specific Pathogen-Free Organisms Support, Non-U.S. Gov't Th2 Cells/*DRUG EFFECTS/IMMUNOLOGY



 




Information in this article was accurate in January 30, 1999. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.